These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8734199)

  • 1. [Local treatments of rectal cancer].
    Lasser P
    J Chir (Paris); 1996 Jan; 133(1):23-36. PubMed ID: 8734199
    [No Abstract]   [Full Text] [Related]  

  • 2. The current management of rectal cancer.
    Ross HM; Mahmoud N; Fry RD
    Curr Probl Surg; 2005 Feb; 42(2):72-131. PubMed ID: 15735619
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognostic evaluation of perineural invasion in rectal cancer.
    Trop Gastroenterol; 1993; 14(2):73-4. PubMed ID: 8291128
    [No Abstract]   [Full Text] [Related]  

  • 4. [Resection or amputation in rectal ampullar cancer].
    Angelescu N; Jitea N; Burcoş T; Constantinescu NM; Bărbulescu M; Nedelcu A; Mircea N; Vlad M
    Chirurgia (Bucur); 1992; 41(2):33-7. PubMed ID: 1364257
    [No Abstract]   [Full Text] [Related]  

  • 5. [Multivariate prognostic analysis of patients with low and middle rectal cancer after curative resection].
    Li CS; Wan DS; Pan ZZ; Zhou ZW; Chen G; Wu XJ; Li LR; Lu ZH; Ding PR; Li Y
    Ai Zheng; 2006 May; 25(5):587-90. PubMed ID: 16687079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy.
    Chan AK; Wong A; Jenken D; Heine J; Buie D; Johnson D
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):665-77. PubMed ID: 15708244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer.
    Luna-Pérez P; Reyna Huelga A; Labastida Almendaro S; Rodríguez-Coria DF; González Macouzet J; Delgado Gallardo S
    Rev Invest Clin; 1999; 51(4):205-13. PubMed ID: 10546501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lateral pelvic lymph node dissection or chemoradiotherapy: which is the procedure of choice to reduce local recurrence rate in lower rectal cancer?
    Watanabe T; Matsuda K; Nozawa K; Kobunai T
    Ann Surg; 2008 Aug; 248(2):342-3; author reply 343. PubMed ID: 18650647
    [No Abstract]   [Full Text] [Related]  

  • 9. Local excision of stratified T1 rectal cancer.
    Wirsing K; Lorenzo-Rivero S; Luchtefeld M; Kim D; Monroe T; Attal H; Hoedema R
    Am J Surg; 2006 Mar; 191(3):410-2. PubMed ID: 16490557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early rectal cancer: local excision or radical surgery?
    Chang AJ; Nahas CS; Araujo SE; Nahas SC; Marques CF; Kiss DR; Cecconello I
    J Surg Educ; 2008; 65(1):67-72. PubMed ID: 18308284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of resection of stage IV rectal cancer with mesorectal excision.
    Law WL; Chu KW
    J Surg Oncol; 2006 Jun; 93(7):523-8. PubMed ID: 16705728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of T1-T2 rectal tumors by contact therapy and interstitial brachytherapy.
    Coatmeur O; Truc G; Barillot I; Horiot JC; Maingon P
    Radiother Oncol; 2004 Feb; 70(2):177-82. PubMed ID: 15028405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic analysis of 384 male patients with rectal cancer].
    Ding PR; Wan DS; Pan ZZ; Zhou ZW; Chen G; Wu XJ; Li LR; Lu ZH; Li CM
    Ai Zheng; 2006 Sep; 25(9):1158-61. PubMed ID: 16965662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinic study of lateral lymph node metastasis in advanced lower rectal cancer].
    Wu ZY; Wan J; Yao Y; Zhao G; Du JL; Yang J
    Zhonghua Wai Ke Za Zhi; 2008 Feb; 46(3):190-2. PubMed ID: 18683713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracapsular spread of nodal metastasis as a prognostic factor in rectal cancer.
    Heide J; Krüll A; Berger J
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):773-8. PubMed ID: 14967433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Risk factors for recurrence and metastasis after radical anterior resection for rectal cancer].
    Wu TC; Shao YF; Li JQ; Wu JX; Zhou ZX; Xu LB; Wang B
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 May; 9(3):210-3. PubMed ID: 16721679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Number and size of lymph nodes recovered from dukes B rectal cancers: correlation with prognosis and histologic antitumor immune response.
    Murphy J; Pocard M; Jass JR; O'Sullivan GC; Lee G; Talbot IC
    Dis Colon Rectum; 2007 Oct; 50(10):1526-34. PubMed ID: 17828403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic analysis of middle and lower rectal cancer with different degrees of infiltration in mesorectum].
    Zhuo HQ; Zhou YB; Lü L; Zhou J; Yang WY; Li YJ
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):820-2. PubMed ID: 19595121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rectal cancer: presentation with metastatic and locally advanced disease. American College of Radiology. ACR Appropriateness Criteria.
    Saltz L; Raben D; Minsky BD; Bader JL; Coia LR; Janjan NA; John MJ; Merrick GS; Rich TA; Rosenthal SA; Tepper JE; Ota D; Leibel S
    Radiology; 2000 Jun; 215 Suppl():1491-9. PubMed ID: 11037562
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognostic markers of local relapse in rectal cancer: are we any further forward?
    Johnston PG
    J Clin Oncol; 2006 Sep; 24(25):4049-50. PubMed ID: 16943520
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.